• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Medcura raises $7.4 Million to Expand FDA-Approved Line of Hemostatic and Wound Treatment Products
Funds will allow Medcura to expand its commercial footprint and support IDE submission for a new class of surgical hemostat RIVERDALE, Md., Aug. 12, 2021 -- (Healthcare Sales & Marketing Network) -- Medcura, Inc., a commercial-stage medical device comp... Devices, Surgery, Venture Capital Medcura, LifeGel, LifeFoam, hemostasis
Source: HSMN NewsFeed - August 12, 2021 Category: Pharmaceuticals Source Type: news

Breakthrough Device Designation received from the FDA
Accelerated regulatory pathway for first internal use product GAITHERSBURG, Md., June 18, 2019 -- (Healthcare Sales & Marketing Network) -- gel-e Inc., announces Breakthrough Status Designation from the U.S. Food and Drug Administration (FDA) for its f... Devices, FDA gel-e , Life Foam, injectable hemostat
Source: HSMN NewsFeed - June 18, 2019 Category: Pharmaceuticals Source Type: news

Cook Medical receives FDA approval for gastrointestinal medical device
Cook Medical has received FDA approval to market in the U.S. a device known as Hemospray that treats gastrointestinal bleeding. The device was developed at Cook's Winston-Salem operations, where the company employs 640 people and ranks as the Triad's sixth-largest life science employer. Based in Bloomington, Indiana, the company employs more than 10,000 worldwide, some 70 percent of whom are located in the U.S. Hemospray, a single-use endoscopic hemostat, treats gastrointestinal bleeding by injecting…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 22, 2018 Category: Pharmaceuticals Authors: Luke Bollinger Source Type: news

New Absorbable Adjunctive Hemostat From Ethicon Helps Surgeons Control Disruptive Bleeding More Efficiently
SURGICEL® Powder is the next innovation in bleeding management designed to help improve operating efficiency SOMERVILLE, N.J., Jan. 9, 2018 -- (Healthcare Sales & Marketing Network) -- Ethicon*, part of the Johnson & Johnson Medical Devices Compani... Devices, Surgery, Product Launch Ethicon, Johnson & Johnson, SURGICEL, ABSORBABLE HEMOSTAT, hemostat
Source: HSMN NewsFeed - January 9, 2018 Category: Pharmaceuticals Source Type: news

Ethicon Announces FDA Approval For SURGICEL(R) Powder Absorbable Hemostat
SOMERVILLE, N.J., June 6, 2017 -- (Healthcare Sales & Marketing Network) -- Uncontrolled bleeding during surgery can adversely affect patient outcomes, hospital costs and resources.1-9 Primary methods of hemostasis alone may be ineffective or impractical,... Devices, Surgery, FDA Ethicon, SURGICEL, Powder Absorbable Hemostat
Source: HSMN NewsFeed - June 6, 2017 Category: Pharmaceuticals Source Type: news

HOYA Group PENTAX Medical Launch HemoStat WideCup(TM), The New Bipolar Hot Hemostasis Forceps Contributing to Early Treatment of Gastric Cancer
TOKYO, Nov. 2, 2016 -- (Healthcare Sales & Marketing Network) -- HOYA Group PENTAX Medical has launched HemoStat WideCupTM, the new bipolar hot hemostasis forceps to achieve easy control of bleeding during endoscopic therapy procedures. The new device wi... Devices, Oncology, Product Launch PENTAX Medical, HOYA Group, HemoStat WideCup, hemostasis, endoscopy
Source: HSMN NewsFeed - November 2, 2016 Category: Pharmaceuticals Source Type: news

CryoLife Provides Update on PerClot Litigation
ATLANTA, March 12, 2015 -- (Healthcare Sales & Marketing Network) -- CryoLife, Inc. (CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, today provided an update on its ongoing litigation with C.R. Bard, I... Devices, Surgery, LitigationCryoLife, C.R. Bard, PerClot, hemostat
Source: HSMN NewsFeed - March 12, 2015 Category: Pharmaceuticals Source Type: news

Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now...
DeepResearchReports.com adds “2015 Market Research Report on Global Hemostat Industry” market research report to its store.(PRWeb February 26, 2015)Read the full story at http://www.prweb.com/releases/global-hemostat-industry/2015-research-report/prweb12546040.htm
Source: PRWeb: Medical Pharmaceuticals - February 26, 2015 Category: Pharmaceuticals Source Type: news

Z-Medica Bolsters Hemostatic Product Line with Acquisition of Novacol(R)
WALLINGFORD, Conn.--(Healthcare Sales & Marketing Network)--Z-Medica, a leading developer and marketer of hemostatic agents, today announced that they have signed a definitive agreement with TAUREON, headquartered in The Netherlands, to acquire Novacol®... Devices, AcquisitionsZ-Medica, TAUREON, Novacol, resorbable hemostat
Source: HSMN NewsFeed - May 5, 2014 Category: Pharmaceuticals Source Type: news

Abyrx(TM), Inc. Announces Option to Acquire Haibo Biotechnology Institute's Soft Tissue Hemostat Technology Platform
IRVINGTON, N.Y., Jan. 27, 2014 -- (Healthcare Sales & Marketing Network) -- Abyrx, Inc., a privately-held therapeutic device company, today announced it has entered the soft tissue hemostasis market with an option to acquire for exclusive development, man... Devices, Surgery, AcquisitionsAbyrx, Haibo Biotechnology Institute, hemostasis, Soft Tissue Hemostat
Source: HSMN NewsFeed - January 27, 2014 Category: Pharmaceuticals Source Type: news

Vascular Solutions Launches ThrombiDisc(TM) Topical Hemostat in U.S.
Novel thrombin-based topical hemostat controls bleeding from vascular access sites Designed specifically for use around indwelling lines up to 12F Contains antimicrobial properties of silver chloride MINNEAPOLIS, Jan. 21, 2014 -- (Healthcare Sales... Devices, Product LaunchVascular Solutions, ThrombiDisc, hemostat, thrombin
Source: HSMN NewsFeed - January 21, 2014 Category: Pharmaceuticals Source Type: news